ODDB.org: Open Drug Database

Roche Pharma (Schweiz) AG - Lunsumio subkutan 5 mg/0.5ml, Injektionslösung

Swissmedic Registration	70221	Sequence	01
Product name	Lunsumio subkutan 5 mg/0.5ml	Description	Injektionslösung
ATC-Classification	L01FX25	ATC-Description	Mosunetuzumab
Introduction of Sequence	03.07.2026

Composition

mosunetuzumabum 5 mg, histidinum, acidum aceticum glaciale, saccharum, methioninum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Mosunetuzumabum	5mg / 0.5ml

Inactive agents
Acidum Aceticum Glaciale
Histidine
Methionine
Polysorbatum 20
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001				A		Yes

2026	©ywesee GmbH